October 26, 2020
GBT
GBT Presents Data at 15th Annual Scientific Conference on Sickle Cell and Thalassemia
October 24, 2020
Revolution Medicines
Revolution Medicines Reports Progress and Expansion of Combination Strategy with RMC-4630 as Therapeutic Backbone for RAS-Addicted Cancers
October 23, 2020
Foundation Medicine
FoundationOne®CDx Receives FDA-Approval as a Companion Diagnostic for VITRAKVI®(larotrectinib) to Identify Patients with NTRK Fusions Across All Solid Tumors
October 22, 2020
Sage Therapeutics
Sage Therapeutics Announces Chief Executive Jeff Jonas to Undergo Scheduled Medical Procedure
October 21, 2020
Rheos Medicines
Rheos Medicines Appoints Dania Rabah, Ph.D., as Chief Scientific Officer